Evidence map›Paper›PMID 31279092›Full record

ArticleFree radical biology & medicine2019

Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.

Jon A Detterich, Honglei Liu, Silvie Suriany, Roberta M Kato, Patjanaporn Chalacheva, Bruke Tedla, Payal M Shah, Michael C Khoo, John C Wood, Thomas D Coates and 4 more

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Association between NADJournal of cellular and molecular medicine · 2022
    Article
  9. Peroxiredoxin-2 recycling is slower in denser and pediatric sickle cell red cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Jon A DetterichDivision of Cardiology, Children's Hospital of Los Angeles, USA. Electronic address: jdetterich@chla.usc.edu.
Honglei LiuDivision of Cardiology, Children's Hospital of Los Angeles, USA.
Silvie SurianyDivision of Cardiology, Children's Hospital of Los Angeles, USA; Division of Hematology, Children's Hospital of Los Angeles, USA.
Roberta M KatoDivision of Pulmonology, USA.
Patjanaporn ChalachevaViterbi School of Engineering, University of Southern California, USA.
Bruke TedlaDivision of Cardiology, Children's Hospital of Los Angeles, USA.
Payal M ShahDivision of Hematology, Children's Hospital of Los Angeles, USA.
Michael C KhooViterbi School of Engineering, University of Southern California, USA.
John C WoodDivision of Cardiology, Children's Hospital of Los Angeles, USA; Viterbi School of Engineering, University of Southern California, USA.
Thomas D CoatesDivision of Hematology, Children's Hospital of Los Angeles, USA.
Ginger L MilneDivision of Clinical Pharmacology, Vanderbilt University, USA.
Joo-Yeun OhDepartment of Pathology and Center for Free Radical Biology, University of Alabama School of Medicine, USA.
Rakesh P PatelDepartment of Pathology and Center for Free Radical Biology, University of Alabama School of Medicine, USA.
Henry Jay FormanLeonard Davis School of Gerontology, University of Southern California, USA.
Children's Hospital of Los Angeles · USUniversity of Southern California · USUniversity of Alabama · USPulmonary Associates · USVanderbilt University · US

Funding

ZOPOLRESTAT IN NORMOTENSIVE, TYPE 1 DIA WITH INCIPIENT NEPHROPATHYM01RR000043 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAIA, JOHN A · 1985 to 2010
$76.4M
TrainingP41EB001978 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KHOO, MICHAEL C K · 2003 to 2017
$18.1M
Neuromodulatory Mechanisms and Regional Autonomic Dysregulation in the Development of Pain in Sickle Cell Disease PatientsU01HL117718 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI COATES, THOMAS DUANE, KHOO, MICHAEL C K · 2013 to 2017
$9.6M
Childrens Hospital Los Angeles Child Health Research Development AwardK12HD052954 · NICHD · CHILDREN'S HOSPITAL OF LOS ANGELES · PI WILLIAMS, ROBERTA GAY · 2006 to 2017
$4.0M
Sickle Cell Scholar ComponentU54HL090511 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI COATES, THOMAS DUANE · 2008 to 2011
$2.6M
Iron-mediated vascular disease in sickle cell disease.RC1HL099412 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI WOOD, JOHN C · 2009 to 2010
$995k
Erythrocyte Nitric Oxide Links Rheology and Vasculopathy in Sickle Cell DiseaseK23HL119627 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI DETTERICH, JON A · 2014 to 2016
$497k
The Impact of Hemoglobin S on Red Blood Cell Nitric Oxide ProductionR03HL138321 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI DETTERICH, JON A · 2017 to 2018
$167k
NCRR NIH HHS M01 RR000043NHLBI NIH HHS K23 HL119627NHLBI NIH HHS L40 HL129393NHLBI NIH HHS R03 HL138321NHLBI NIH HHS RC1 HL099412NHLBI NIH HHS U01 HL117718NHLBI NIH HHS U54 HL090511NIBIB NIH HHS P41 EB001978NICHD NIH HHS K12 HD052954
6 · The paper itself

Abstract

Sickle cell disease (SCD) is a monogenetic disease that results in the formation of hemoglobin S. Due to more rapid oxidation of hemoglobin S due to intracellular heme and adventitious iron in SCD, it has been thought that an inherent property of SCD red cells would be an imbalance in antioxidant defenses and oxidant production. Less deformable and fragile RBC in SCD results in intravascular hemolysis and release of free hemoglobin (PFHb) in the plasma, which might be expected to produce oxidative stress in the plasma. Thus, we aimed to characterize intracellular and vascular oxidative stress in whole blood and plasma samples from adult SCD patients and controls recruited into a large study of SCD at Children's Hospital of Los Angeles. We evaluated the cellular content of metHb and several components of the antioxidant system in RBC as well as oxidation of GSH and Prx-2 oxidation in RBC after challenge with hydroperoxides. Plasma markers included PFHb, low molecular weight protein bound heme (freed heme), hemopexin, isoprostanes, and protein carbonyls. While GSH was slightly lower in SCD RBC, protein carbonyls, NADH, NAD

Indexed as

AdolescentAdultAnemia, Sickle CellChildErythrocytesFemaleGlutathioneHemeHemoglobin AHemoglobin, SickleHemopexinHumansIsoprostanesMaleMethemoglobinOxidation-ReductionGlutathioneHemeHemoglobin AHemoglobin, SickleHemopexinIsoprostanesMethemoglobinmethemoglobin A

Identifiers

PMID31279092
PMCPMC6750280
OpenAlexW2954900358

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.